Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV004770515 | SCV005379370 | uncertain significance | not provided | 2023-11-08 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function |
Ambry Genetics | RCV005269049 | SCV005932050 | uncertain significance | Inborn genetic diseases | 2024-12-20 | criteria provided, single submitter | clinical testing | The p.M1323I variant (also known as c.3969G>A), located in coding exon 13 of the ASXL1 gene, results from a G to A substitution at nucleotide position 3969. The methionine at codon 1323 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |